Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2023-2033
The global Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is valued at US$15.6 billion in 2023 and is projected to grow at a CAGR of 7.4% during the forecast period 2023-2033.